or Try an Advanced Search...

    U.S. Food And Drug Administration Stocks List

    Symbol Grade Name % Change
    DRRX F DURECT Corporation -14.02
    BWAY D Brainsway Ltd. -0.36
    SBIO D ALPS Medical Breakthroughs ETF 0.75
    ETON F Eton Pharmaceutcials, Inc. 2.25
    CYTK D Cytokinetics, Incorporated 2.54
    PLRX D Pliant Therapeutics, Inc. 3.44
    SNPX D Synaptogenix, Inc. 5.31
    LSTA D Lisata Therapeutics, Inc. 6.67
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Neuroscience Pharmaceutical Amyotrophic Lateral Sclerosis Biotechnology Disease Drug Design FDA Medicine Multiple Sclerosis Opioids Orphan Drug Pain Stroke Acid Addiction Adhd Alcohol Allergic Conjunctivitis Alzheimer's Disease

    Related ETFs - A few ETFs which own one or more of the above listed U.S. Food And Drug Administration stocks.

    Symbol Grade Name Weight
    HRTS F Tema Cardiovascular and Metabolic ETF 2.8
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.03
    BTEC C Principal Healthcare Innovators Index ETF 1.61
    XBI C SPDR S&P Biotech ETF 1.07
    BBH B Market Vectors Biotech ETF 0.81
    View all U.S. Food And Drug Administration ETFs...
    Compare ETFs
    Compare BBC to BBH Compare BTEC to BBH Compare HRTS to XBI

        U.S. Food And Drug Administration Stocks Recent News

        Date Stock Title
        May 14 DRRX Q1 2024 DURECT Corp Earnings Call
        May 14 PLRX Pliant reports phase 2 data on idiopathic pulmonary fibrosis asset bexotegrast
        May 14 PLRX Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
        May 14 DRRX Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...
        May 14 DRRX DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript
        May 13 CYTK Health Care Roundup: Market Talk
        May 13 DRRX Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
        May 13 DRRX DURECT GAAP EPS of -$0.25 misses by $0.03, revenue of $1.83M misses by $0.9M
        May 13 DRRX DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
        May 13 CYTK Cytokinetics Reveals More From The Study That Boosted Shares 83%
        May 13 CYTK Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine
        May 13 CYTK Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
        May 12 DRRX DURECT Q1 2024 Earnings Preview
        May 12 ETON Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
        May 11 ETON Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript
        May 10 LSTA Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
        May 10 CYTK Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
        May 10 LSTA Q1 2024 Lisata Therapeutics Inc Earnings Call
        May 10 ETON Q1 2024 Eton Pharmaceuticals Inc Earnings Call
        May 10 CYTK Cytokinetics First Quarter 2024 Earnings: Misses Expectations
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Neuroscience Pharmaceutical Amyotrophic Lateral Sclerosis Biotechnology Disease Drug Design FDA Medicine Multiple Sclerosis Opioids Orphan Drug Pain Stroke Acid Addiction Adhd Alcohol Allergic Conjunctivitis Alzheimer's Disease
        U.S. Food And Drug Administration

        Browse All Tags